120 related articles for article (PubMed ID: 26660672)
1. The Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic Cancers.
Kenmogne LC; Ayan D; Roy J; Maltais R; Poirier D
PLoS One; 2015; 10(12):e0144890. PubMed ID: 26660672
[TBL] [Abstract][Full Text] [Related]
2. Induction of endoplasmic reticulum stress by aminosteroid derivative RM-581 leads to tumor regression in PANC-1 xenograft model.
Perreault M; Maltais R; Roy J; Picard S; Popa I; Bertrand N; Poirier D
Invest New Drugs; 2019 Jun; 37(3):431-440. PubMed ID: 30062573
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models.
Zajchowski DA; Biroc SL; Liu HL; Chesney SK; Hoffmann J; Bauman J; Kirkland T; Subramanyam B; Shen J; Ho E; Tseng JL; Dinter H
Int J Cancer; 2005 May; 114(6):1002-9. PubMed ID: 15645422
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of human tumor xenografts in nude mice by treatment with the antitumor agent 4,6-benzylidene-d1-D-glucose (P-1013).
Dunsaed CB; Dornish JM; Aastveit TE; Nesland JM; Pettersen EO
Anticancer Drugs; 1995 Jun; 6(3):456-64. PubMed ID: 7670145
[TBL] [Abstract][Full Text] [Related]
5. Chemical synthesis, NMR analysis and evaluation on a cancer xenograft model (HL-60) of the aminosteroid derivative RM-133.
Maltais R; Hospital A; Delhomme A; Roy J; Poirier D
Steroids; 2014 Apr; 82():68-76. PubMed ID: 24486462
[TBL] [Abstract][Full Text] [Related]
6. Explorative study on the anticancer activity, selectivity and metabolic stability of related analogs of aminosteroid RM-133.
Perreault M; Maltais R; Dutour R; Poirier D
Steroids; 2016 Nov; 115():105-113. PubMed ID: 27553727
[TBL] [Abstract][Full Text] [Related]
7. A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines.
Nio Y; Ohmori H; Minari Y; Hirahara N; Sasaki S; Takamura M; Tamura K
Anticancer Drugs; 1997 Aug; 8(7):686-95. PubMed ID: 9311445
[TBL] [Abstract][Full Text] [Related]
8. Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model.
Yu L; Wang Y; Yao Y; Li W; Lai Q; Li J; Zhou Y; Kang T; Xie Y; Wu Y; Chen X; Yi C; Gou L; Yang J
Int J Gynecol Cancer; 2014 Sep; 24(7):1158-64. PubMed ID: 24987913
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice.
Gründker C; Völker P; Griesinger F; Ramaswamy A; Nagy A; Schally AV; Emons G
Am J Obstet Gynecol; 2002 Sep; 187(3):528-37. PubMed ID: 12237622
[TBL] [Abstract][Full Text] [Related]
10. Parallel Solid-Phase Synthesis using a New Diethylsilylacetylenic Linker and Leading to Mestranol Derivatives with Potent Antiproliferative Activities on Multiple Cancer Cell Lines.
Dutour R; Maltais R; Perreault M; Roy J; Poirier D
Anticancer Agents Med Chem; 2018; 18(10):1469-1481. PubMed ID: 29521249
[TBL] [Abstract][Full Text] [Related]
11. A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits tumor growth in xenografts.
Kawakami K; Hattori M; Inoue T; Maruyama Y; Ohkanda J; Kato N; Tongu M; Yamada T; Akimoto M; Takenaga K; Sassa T; Suzumiy J; Honma Y
Anticancer Agents Med Chem; 2012 Sep; 12(7):791-800. PubMed ID: 22263802
[TBL] [Abstract][Full Text] [Related]
12. Chemical synthesis, cytotoxicity, selectivity and bioavailability of 5α-androstane-3α,17β-diol derivatives.
Ayan D; Maltais R; Hospital A; Poirier D
Bioorg Med Chem; 2014 Nov; 22(21):5847-59. PubMed ID: 25300820
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
Lu YY; Jing DD; Xu M; Wu K; Wang XP
World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
Nambiar D; Prajapati V; Agarwal R; Singh RP
Cancer Lett; 2013 Jun; 334(1):109-17. PubMed ID: 23022268
[TBL] [Abstract][Full Text] [Related]
16. Effective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers.
Gründker C; Ernst J; Reutter MD; Ghadimi BM; Emons G
Oncol Rep; 2011 Sep; 26(3):629-35. PubMed ID: 21667032
[TBL] [Abstract][Full Text] [Related]
17. Design of a Mestranol 2-N-Piperazino-Substituted Derivative Showing Potent and Selective in vitro and in vivo Activities in MCF-7 Breast Cancer Models.
Perreault M; Maltais R; Roy J; Dutour R; Poirier D
ChemMedChem; 2017 Jan; 12(2):177-182. PubMed ID: 28060448
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts.
van Laar ES; Izbicka E; Weitman S; Medina-Gundrum L; Macdonald JR; Waters SJ
Int J Gynecol Cancer; 2004; 14(5):824-31. PubMed ID: 15361190
[TBL] [Abstract][Full Text] [Related]
19. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
[TBL] [Abstract][Full Text] [Related]
20. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
